Ion Beam Applications SA (IBAB)

Currency in EUR
13.78
-0.32(-2.27%)
Closed·

IBAB Earnings

Latest Release
Mar 27, 2026
EPS / Forecast
-- / --
Revenue / Forecast
315.3M / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2025/12--/--315.30M/------Free Sign Up
2025/06--/--304.90M/------Free Sign Up
2024/120.660/--291.71M/------Free Sign Up
2024/09--/----/------Free Sign Up
2024/06-0.350/--206.45M/------Free Sign Up
2024/03--/----/------Free Sign Up
2023/12--/----/250.00M----Free Sign Up
2023/09--/----/------Free Sign Up
2023/06--/----/------Free Sign Up
2023/03--/----/------Free Sign Up

All numbers in EUR

Ion Beam Applications SA Earnings Call Summary for Q3/2025

  • IBA reported Q3 2025 order intake of €195 million (+€11M YoY), maintained a €1.3B backlog, and secured €135M in financing to strengthen its balance sheet.
  • The company acquired Phantomics to enhance medical imaging capabilities and signed an MoU with Varian to improve proton therapy interoperability.
  • Despite regulatory pressures in ETO sterilization, IBA maintains strong positioning in proton therapy, particularly in the APAC region.
  • Management reaffirmed 2025 guidance of at least $25M EBIT, with CFO Catherine Vandenborre highlighting promising developments in theranostics.
  • IBA expects gradual improvement in net financial position starting December 2025, with proton therapy projects extending beyond 2026.
Last Updated: 2025-11-20, 11:18 a/m
Read Full Transcript

FAQ

What Is Ion Beam Applications's Earnings Per Share (TTM)?

The Ion Beam Applications EPS (TTM) is 0.43.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.